Alcoholism Market Analysis and Reports | Malaysia Conference Series

Market Analysis - Alcoholism 2017

Addictive Disorders and Alcoholism welcomes attendees, presenters, and exhibitors from all over the world to Kuala Lumpur, Malaysia. We are delighted to invite you all to attend and register for the 7th International Conference on Addictive Disorders and Alcoholism which is going to be held during July 3-4, 2017 at Kuala Lumpur, Malaysia. The organizing committee is gearing up for an exciting and informative conference program including Keynote presentation, plenary lectures, symposia, workshops and poster presentations on various topics related to Addictive Disorders and Alcoholism around the theme Alcoholism and Drug Addiction Diseases, Treatment, and Recovery.

Importance and Scope:

Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social and spiritual manifestations. This is reflected in an individual pathologically pursuing reward and/or relief by substance use and other behaviors.

Addiction is an essential, chronic disease of brain reward, inspiration, memory and related circuitry. Brokenness in these circuits prompts to characteristic biological, mental, social and profound appearances. This is reflected in an individual pathologically seeking after reward and additionally alleviation by substance utilize and different practices.

Addiction Science gives a gathering to important research and viewpoints that add to enhancing the nature of look after individuals with unfortunate liquor, tobacco, or other medications utilize and addictive practices over a range. Points of intrigue deliver issues identified with the accompanying: the range of unfortunate utilization of liquor, tobacco, and different medications among the scope of influenced people the variety of clinical anticipation and treatment practices and recognizable proof and administration of medicinal, psychiatric, social, and other wellbeing results of substance utilize.

As indicated by Australian scientists the first since forever give an account of overall enslavement insights. They found around 240 million individuals around the globe are reliant on liquor, more than a billion people smoke, and around 15 million individuals utilize infusion medications, for example, heroin.

The report utilizes information from sources including the World Health Organization and the United Nations Office on Drugs and Crime, as indicated by NPR. The analysts say the report is critical in light of the fact that it gives a gauge of medication and liquor utilize around the world, alongside examinations among various locales.

As indicated by the report, individuals in Eastern Europe smoke and drink more than any other person on the planet, while Asians drink the minimum. "One thing that emerges is nations that are overwhelmingly Muslim have a much lower rate of liquor utilization. Liquor utilization is likewise lower at all created nations, the report found.

In the UK, figures for medication clients exhibiting for treatment identified with tricky medication abuse are drawn specifically from the National Drug Treatment Monitoring System (NDTMS). The NDTMS identifies with the way toward gathering, grouping and examining data from and for those included in the medication treatment segment. The NDTMS is an advancement of the local medication abuse databases (RDMDs), which have been set up since the late 1980s.

The most recent measurements from the NDTMS demonstrate that in 2011-12 there were 197,110 people matured 18 and over who were in treatment, with 69,434 of those having begun new treatment travels in that year. Of the 63,020 that left treatment that year, 29,855 (45%) left in the wake of having finished their treatment and beat their reliance on the medication for which treatment was looked for.

Why Kuala Lumpur, Malaysia?

Kuala is the national capital of Malaysia as well as its largest city. The city covers an area of 243 km2 (94 sq. mi) and has an estimated population of 1.7 million as of 2015. It is one of the major Addiction hubs in Malaysia. There are about 500 retreat centers in Kuala Lumpur. Prestigious universities of the country are working in the field of Addiction Therapy. It features Best Addiction research centers, Rehabilitation Centres & Counseling Centres; many addictions related Associations and Societies. Top universities of Malaysia are into addiction research.

Conference Highlights!!

·         Addiction

·         Addiction Medicine

·         Addiction Nursing

·         Addiction treatment and rehabilitation

·         Addictive Disorders 

·         Alcoholism

·         Behavioral addiction

·         Child & Adolescent Substance Abuse

·         Depression & Anxiety Disorders

·         Drug Addiction

·         Eating Disorders

·         Gambling Addiction

·         Group therapies

·         Liver Cirrhosis

·         Marijuana and Opioid Addiction

·         Mental Health and Substance Abuse

·         Rehabilitation Therapies 

Why attend??

With members from around the world focused on learning about Alcoholism and Drug Addiction Disease, Treatment and Recovery. The conference brings together some of the latest, most thought-provoking research from around the world. In a small and intimate setting, researchers and clinicians from all corners of the world are able to exchange ideas, share findings and discuss future collaborations. This will produce a broader international knowledge-base and wonderful advances in the field of Addictive Disorders and Alcoholism. World-renowned speakers, the most recent techniques, and the newest updates in Alcoholism and Addictive Disorders and Therapy are hallmarks of this Conference.

Addictive Disorders and Alcoholism Conference includes prompt Keynote presentations, Workshops, Oral talks, Poster presentations, Video presentations, e-poster and Exhibitions.

A Unique Opportunity for Advertisers and Sponsors at this International event

Major Addiction Associations and Societies around the Globe

·         Canadian Centre on Substance Abuse (CCSA)

·         Centre for Addiction and Mental Health (CAMH)

·         European Association for the Treatment of Addiction (EATA)

·         European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

·         European Opiate Treatment Association (EUROPAD)

·         International AIDS Society (IAS)

·         International Harm Reduction Association

·         International Society of Addiction Medicine (ISAM)

·         Society for the Study of Addictions (SSA)

·         Canadian Society of Addiction Medicine (CSAM)

·         International Coalition for Addiction Studies Education (INCASE)

Top Universities in Kuala Lumpur:

·         International Medical University

·         UCSI University South Wing

·         Perdana University

·         University of Malaya

·         Kuala Lumpur Metropolitan University College

Target Audience:

Noble laureates, Presidents, Vice-presidents, Chairs, Co-chairs, Department Heads, Non-PhD Students, PhD Students, etc. Vendors will have the opportunity to introduce the latest advancements in Addiction sciences to a diverse audience by becoming a conference sponsor via exhibits and/or workshops.

  • Industry          21%
  • Student           17%
  • Academia       42%
  • Government   11%
  • Others              9%

Projection: Growth by next 5-10 years

AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Pfizer, Johnson & Johnson, and GlaxoSmithKline. Eli Lilly: Zyprexa drug has the largest market share of the market, at 26% ($4.70 billion). AstraZeneca: Seroquel, at 2nd place ($4.45 billion) remains the most widely prescribed antipsychotic. Bristol-Myers Squibb: Abilify saw a 30% growth in sales from 2007 to 2008 to $2.15 billion. Zyprexa earned revenues of $4.70 billion in 2008, representing 23% of Eli Lilly's total earnings in that year. Total sales for Zyprexa decreased 1% from 2007 to 2008, due to decreased demand from increased generic competition. Zyprexa was approved in 2000 to treat schizophrenia. Eli Lilly's patent for Zyprexa expires on April 23, 2011. Abilify earned revenues of $2.15 billion in 2008 for a growth of 30% from 2007 to 2008. Abilify was approved in 2007 as an adjunctive treatment for major depressive disorder as well as a therapeutic for schizophrenia and bipolar disorder in adolescents. J&J's antipsychotics franchise, including the Risperdal formulations and Invega, earned revenues of $3.8 billion in 2008; a decrease of 24% from 2007 to 2008. Invega was approved in 2007 by the FDA to treat schizophrenia.

Major drugs Companies the world is:

  • AstraZeneca
  • Universal Health Services Inc.
  • Johnson & Johnson
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Bristol-Meyer Squibb
  • Wyeth
  • AstellasPharma Inc. and more


Addictive Disorders and Alcoholism 2017 is a two-days event provides a perfect platform for leading scientists, researchers, decision-makers and other players to gain the latest information on topics of current research like Addiction, Alcoholism, Marijuana and Opioid Addiction, Depression & Anxiety Disorders, Eating Disorders, Addiction Treatment and Rehabilitation, etc. Addictive Disorders and Alcoholism Conference includes prompt Keynote presentations, Workshops, Oral talks, Poster presentations, Video presentations, e-poster, and Exhibitions.